Data from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Published in 2023 by
Andrea Wang-Gillam,
Kian-Huat Lim,
Robert McWilliams 
,
Rama Suresh,
Albert C. Lockhart,
Amberly Brown ,
Marcus Breden,
Jad I. Belle,
John Herndon ,
Savannah J. Bogner,
Katrina Pedersen,
Benjamin Tan,
Nicholas Boice,
Abhi Acharya,
Mina Abdiannia
and other authors.
,
Rama Suresh,
Albert C. Lockhart,
Amberly Brown ,
Marcus Breden,
Jad I. Belle,
John Herndon ,
Savannah J. Bogner,
Katrina Pedersen,
Benjamin Tan,
Nicholas Boice,
Abhi Acharya,
Mina Abdiannia
and other authors.
